搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Yarrowia lipolytica U2 small nuclear ribonucleoprotein A' (LEA1) CSB-YP724650YAP
CSB-EP724650YAP
CSB-BP724650YAP
CSB-MP724650YAP
CSB-EP724650YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Adenylosuccinate synthetase (YALI0E28963g) CSB-YP724651YAP
CSB-EP724651YAP
CSB-BP724651YAP
CSB-MP724651YAP
CSB-EP724651YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Histone H2B (HTB1) CSB-YP724652YAP
CSB-EP724652YAP
CSB-BP724652YAP
CSB-MP724652YAP
CSB-EP724652YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Cx9C motif-containing protein 4, mitochondrial (CMC4) CSB-YP724653YAP
CSB-EP724653YAP
CSB-BP724653YAP
CSB-MP724653YAP
CSB-EP724653YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica UDP-galactose transporter homolog 1 (HUT1), partial CSB-YP724654YAP
CSB-EP724654YAP
CSB-BP724654YAP
CSB-MP724654YAP
CSB-EP724654YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Cytosolic Fe-S cluster assembly factor CFD1 (CFD1) CSB-YP724655YAP
CSB-EP724655YAP
CSB-BP724655YAP
CSB-MP724655YAP
CSB-EP724655YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Protein SDS23 (SDS23), partial CSB-YP724656YAP
CSB-EP724656YAP
CSB-BP724656YAP
CSB-MP724656YAP
CSB-EP724656YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Vacuolar protein 8 (VAC8), partial CSB-YP724657YAP
CSB-EP724657YAP
CSB-BP724657YAP
CSB-MP724657YAP
CSB-EP724657YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica IMP-specific 5'-nucleotidase 1 (ISN1) CSB-YP724658YAP
CSB-EP724658YAP
CSB-BP724658YAP
CSB-MP724658YAP
CSB-EP724658YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Autophagy-related protein 2 (ATG2), partial CSB-YP724659YAP
CSB-EP724659YAP
CSB-BP724659YAP
CSB-MP724659YAP
CSB-EP724659YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Mitochondrial genome maintenance protein MGM101 (MGM101) CSB-YP724660YAP
CSB-EP724660YAP
CSB-BP724660YAP
CSB-MP724660YAP
CSB-EP724660YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Serine/threonine-protein phosphatase 2A activator 2 (RRD2) CSB-YP724661YAP
CSB-EP724661YAP
CSB-BP724661YAP
CSB-MP724661YAP
CSB-EP724661YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Transcription activator of gluconeogenesis ERT1-2 (ERT1-2), partial CSB-YP724662YAP
CSB-EP724662YAP
CSB-BP724662YAP
CSB-MP724662YAP
CSB-EP724662YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica ATP-dependent DNA helicase II subunit 2 (KU80), partial CSB-YP724663YAP
CSB-EP724663YAP
CSB-BP724663YAP
CSB-MP724663YAP
CSB-EP724663YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica DNA replication regulator SLD2 (SLD2) CSB-YP724664YAP
CSB-EP724664YAP
CSB-BP724664YAP
CSB-MP724664YAP
CSB-EP724664YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Thioredoxin reductase (TRR1) CSB-YP724665YAP
CSB-EP724665YAP
CSB-BP724665YAP
CSB-MP724665YAP
CSB-EP724665YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Putative heme-binding peroxidase (YALI0D25366g) CSB-YP724666YAP
CSB-EP724666YAP
CSB-BP724666YAP
CSB-MP724666YAP
CSB-EP724666YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Mitochondrial import inner membrane translocase subunit TIM54 (TIM54), partial CSB-YP724667YAP1
CSB-EP724667YAP1
CSB-BP724667YAP1
CSB-MP724667YAP1
CSB-EP724667YAP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Enhancer of translation termination 1 (ETT1) CSB-YP724668YAP
CSB-EP724668YAP
CSB-BP724668YAP
CSB-MP724668YAP
CSB-EP724668YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Pre-mRNA-splicing factor CEF1 (CEF1), partial CSB-YP724669YAP
CSB-EP724669YAP
CSB-BP724669YAP
CSB-MP724669YAP
CSB-EP724669YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>